Pituitary gonadotropin inhibitory activity of danazol.
D000311:Adrenal Glands / Q000033:anatomy & histology; D000728:Androgens / Q000494:pharmacology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002369:Castration; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000494:pharmacology*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D005260:Female; D005298:Fertility / Q000187:drug effects; D006065:Gonadotropins, Pituitary / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D008598:Menstruation; D008777:Methyltestosterone / Q000494:pharmacology; D008795:Metronidazole / Q000494:pharmacology*; D009929:Organ Size; D010053:Ovary / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology; D010902:Pituitary Gland / Q000033:anatomy & histology; D011247:Pregnancy; D011372:Progestins / Q000494:pharmacology; D011467:Prostate / Q000033:anatomy & histology; D011817:Rabbits; D051381:Rats; D013737:Testis / Q000033:anatomy & histology; D013950:Thymus Gland / Q000033:anatomy & histology; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects; D014621:Vagina / Q000187:drug effects
D000728:Androgens; D003276:Contraceptives, Oral; D006065:Gonadotropins, Pituitary; D011372:Progestins; D008795:Metronidazole; D008777:Methyltestosterone